Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 1/20 | 0.34 |
| ▸ | RXRG | P48443 | 1/20 | 0.34 |
| ▸ | KIF11 | P52732 | 3/20 | 0.34 |
| ▸ | MAT2A | P31153 | 1/20 | 0.32 |
| ▸ | RAPGEF3 | O95398 | 3/20 | 0.32 |
| ▸ | RAPGEF4 | Q8WZA2 | 2/20 | 0.32 |
| ▸ | XDH | P47989 | 1/20 | 0.31 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.31 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.31 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.31 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.31 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.31 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19912463 | 0.95 | KIF11 (0.34) | RXRARXRGKIF11MAT2A | |
| SCHEMBL19918009 | 0.93 | KIF11 (0.37) | RXRARXRGKIF11MAT2ARAPGEF3 | |
| SCHEMBL22822245 | 0.93 | RXRA (0.39) | RXRARXRGKIF11MAT2ARAPGEF3 | |
| SCHEMBL19912483 | 0.92 | KIF11 (0.38) | RXRARXRGKIF11MAT2AXDH | |
| SCHEMBL19912465 | 0.92 | RXRA (0.34) | RXRARXRGKIF11MAT2AXDH | |
| SCHEMBL19912385 | 0.91 | RXRA (0.36) | RXRARXRGKIF11MAT2AXDH | |
| SCHEMBL19912466 | 0.90 | KIF11 (0.39) | RXRARXRGKIF11MAT2A | |
| SCHEMBL19912496 | 0.89 | RXRA (0.39) | RXRARXRGKIF11MAT2AXDH | |
| SCHEMBL19912489 | 0.89 | AR (0.40) | RXRARXRGKIF11MAT2AXDH | |
| SCHEMBL19903636 | 0.88 | KIF11 (0.37) | RXRARXRGKIF11MAT2ARAPGEF3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180062086-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180062086-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, ORC3, AOC3 | RXRA 3635/4885RXRG 3474/4885KIF11 3316/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.